

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 9.04053330 |
| 2 | polyketide metabolic process (GO:0030638) | 9.04053330 |
| 3 | doxorubicin metabolic process (GO:0044598) | 9.04053330 |
| 4 | protein localization to kinetochore (GO:0034501) | 6.27835497 |
| 5 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.82038833 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.75309099 |
| 7 | histone H4-K12 acetylation (GO:0043983) | 5.37873429 |
| 8 | type I interferon signaling pathway (GO:0060337) | 5.31189670 |
| 9 | cellular response to type I interferon (GO:0071357) | 5.31189670 |
| 10 | response to type I interferon (GO:0034340) | 5.31011128 |
| 11 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.23609930 |
| 12 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.23206580 |
| 13 | histone H4-K8 acetylation (GO:0043982) | 5.03116055 |
| 14 | histone H4-K5 acetylation (GO:0043981) | 5.03116055 |
| 15 | mitotic sister chromatid segregation (GO:0000070) | 5.01519619 |
| 16 | negative regulation of epidermis development (GO:0045683) | 4.97792757 |
| 17 | somite rostral/caudal axis specification (GO:0032525) | 4.90613350 |
| 18 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.83710207 |
| 19 | nuclear pore complex assembly (GO:0051292) | 4.82729303 |
| 20 | heterochromatin organization (GO:0070828) | 4.82328511 |
| 21 | protein localization to chromosome, centromeric region (GO:0071459) | 4.81355631 |
| 22 | muscle organ morphogenesis (GO:0048644) | 4.78332414 |
| 23 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.65060023 |
| 24 | rRNA transcription (GO:0009303) | 4.64194477 |
| 25 | regulation of response to osmotic stress (GO:0047484) | 4.63720619 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49877392 |
| 27 | interferon-gamma production (GO:0032609) | 4.44973519 |
| 28 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.44343550 |
| 29 | nuclear pore organization (GO:0006999) | 4.36451348 |
| 30 | sister chromatid segregation (GO:0000819) | 4.32536702 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29591866 |
| 32 | chromatin assembly (GO:0031497) | 4.27770636 |
| 33 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.27314600 |
| 34 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.27314600 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19773646 |
| 36 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.16171427 |
| 37 | DNA replication checkpoint (GO:0000076) | 4.12611984 |
| 38 | response to peptidoglycan (GO:0032494) | 4.12598497 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.10265238 |
| 40 | pre-miRNA processing (GO:0031054) | 3.99585446 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 3.96070561 |
| 42 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.95038475 |
| 43 | histone H4-K16 acetylation (GO:0043984) | 3.92688692 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.92384135 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 3.86515725 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.78071245 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.76686894 |
| 48 | negative regulation of cell killing (GO:0031342) | 3.76686894 |
| 49 | notochord development (GO:0030903) | 3.75989675 |
| 50 | cytidine deamination (GO:0009972) | 3.75133277 |
| 51 | cytidine metabolic process (GO:0046087) | 3.75133277 |
| 52 | cytidine catabolic process (GO:0006216) | 3.75133277 |
| 53 | regulation of gene silencing by RNA (GO:0060966) | 3.73739596 |
| 54 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.73739596 |
| 55 | regulation of gene silencing by miRNA (GO:0060964) | 3.73739596 |
| 56 | * maintenance of protein location in nucleus (GO:0051457) | 3.73257829 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.72376786 |
| 58 | rRNA methylation (GO:0031167) | 3.71366104 |
| 59 | DNA unwinding involved in DNA replication (GO:0006268) | 3.69262203 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.67759894 |
| 61 | pore complex assembly (GO:0046931) | 3.67337487 |
| 62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67286791 |
| 63 | modulation by symbiont of host defense response (GO:0052031) | 3.67286791 |
| 64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67286791 |
| 65 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67286791 |
| 66 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67286791 |
| 67 | modulation by symbiont of host immune response (GO:0052553) | 3.67286791 |
| 68 | RNA stabilization (GO:0043489) | 3.66214091 |
| 69 | mRNA stabilization (GO:0048255) | 3.66214091 |
| 70 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.66151119 |
| 71 | DNA duplex unwinding (GO:0032508) | 3.65264804 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.62704563 |
| 73 | DNA geometric change (GO:0032392) | 3.60853609 |
| 74 | nucleoside transmembrane transport (GO:1901642) | 3.59699648 |
| 75 | negative regulation of viral genome replication (GO:0045071) | 3.55876445 |
| 76 | germinal center formation (GO:0002467) | 3.54883986 |
| 77 | response to interferon-alpha (GO:0035455) | 3.52233100 |
| 78 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.51800605 |
| 79 | rRNA modification (GO:0000154) | 3.51028485 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.50890205 |
| 81 | response to muramyl dipeptide (GO:0032495) | 3.45818523 |
| 82 | defense response to protozoan (GO:0042832) | 3.44824919 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.43125456 |
| 84 | formation of translation preinitiation complex (GO:0001731) | 3.42517329 |
| 85 | cellular response to exogenous dsRNA (GO:0071360) | 3.41295768 |
| 86 | positive regulation of interferon-alpha production (GO:0032727) | 3.40864582 |
| 87 | primitive streak formation (GO:0090009) | 3.39755659 |
| 88 | detection of other organism (GO:0098543) | 3.39594919 |
| 89 | detection of bacterium (GO:0016045) | 3.39578419 |
| 90 | hormone catabolic process (GO:0042447) | 3.39308530 |
| 91 | response to protozoan (GO:0001562) | 3.37828271 |
| 92 | myeloid dendritic cell differentiation (GO:0043011) | 3.37051260 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.36838051 |
| 94 | trophectodermal cell differentiation (GO:0001829) | 3.35008053 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33250867 |
| 96 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.32584132 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 3.31822414 |
| 98 | T-helper 1 type immune response (GO:0042088) | 3.31477428 |
| 99 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.29860517 |
| 100 | response to interferon-beta (GO:0035456) | 3.28646031 |
| 101 | ribosome biogenesis (GO:0042254) | 3.28639882 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 3.28383902 |
| 103 | negative regulation of gene silencing (GO:0060969) | 3.28218509 |
| 104 | mitotic chromosome condensation (GO:0007076) | 3.27411948 |
| 105 | maternal placenta development (GO:0001893) | 3.24141238 |
| 106 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19451147 |
| 107 | positive regulation of antigen processing and presentation (GO:0002579) | 3.13119285 |
| 108 | cellular response to interferon-alpha (GO:0035457) | 3.08526931 |
| 109 | DNA replication initiation (GO:0006270) | 3.08087690 |
| 110 | regulation of DNA-dependent DNA replication (GO:0090329) | 3.06408122 |
| 111 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06092775 |
| 112 | cellular response to virus (GO:0098586) | 3.04854726 |
| 113 | ribosomal small subunit biogenesis (GO:0042274) | 3.04440344 |
| 114 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.03933343 |
| 115 | regulation of type 2 immune response (GO:0002828) | 3.03772549 |
| 116 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.02274462 |
| 117 | regulation of cilium movement (GO:0003352) | 3.00727667 |
| 118 | myeloid dendritic cell activation (GO:0001773) | 2.98815579 |
| 119 | intestinal epithelial cell development (GO:0060576) | 2.97745541 |
| 120 | regulation of chronic inflammatory response (GO:0002676) | 2.97098577 |
| 121 | phenol-containing compound catabolic process (GO:0019336) | 2.95743236 |
| 122 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93518908 |
| 123 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.93226857 |
| 124 | negative regulation of innate immune response (GO:0045824) | 2.92090227 |
| 125 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.91160227 |
| 126 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.89767581 |
| 127 | establishment of endothelial barrier (GO:0061028) | 2.88940409 |
| 128 | spindle assembly (GO:0051225) | 2.88457621 |
| 129 | quinone metabolic process (GO:1901661) | 2.88331456 |
| 130 | leukocyte aggregation (GO:0070486) | 2.87692736 |
| 131 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.86485941 |
| 132 | regulation of gene silencing (GO:0060968) | 2.86252336 |
| 133 | * cellular response to interferon-gamma (GO:0071346) | 2.85688548 |
| 134 | regulation of chemokine biosynthetic process (GO:0045073) | 2.85588381 |
| 135 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.85419965 |
| 136 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.84608935 |
| 137 | mature B cell differentiation involved in immune response (GO:0002313) | 2.84263507 |
| 138 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84195401 |
| 139 | mitotic nuclear envelope disassembly (GO:0007077) | 2.84082511 |
| 140 | regulation of vitamin metabolic process (GO:0030656) | 2.84009582 |
| 141 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.83195822 |
| 142 | histone H3-K4 methylation (GO:0051568) | 2.83144041 |
| 143 | detection of external biotic stimulus (GO:0098581) | 2.82662410 |
| 144 | transcription from mitochondrial promoter (GO:0006390) | 2.82145602 |
| 145 | B cell mediated immunity (GO:0019724) | 2.81357674 |
| 146 | pseudouridine synthesis (GO:0001522) | 2.80419801 |
| 147 | T cell migration (GO:0072678) | 2.80112575 |
| 148 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.78529171 |
| 149 | negative regulation of phagocytosis (GO:0050765) | 2.78058769 |
| 150 | response to dietary excess (GO:0002021) | 2.77891274 |
| 151 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76077051 |
| 152 | activation of MAPKKK activity (GO:0000185) | 2.75756151 |
| 153 | DNA conformation change (GO:0071103) | 2.75164784 |
| 154 | mitochondrial DNA replication (GO:0006264) | 2.74318819 |
| 155 | mitochondrion distribution (GO:0048311) | 2.73808776 |
| 156 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73469570 |
| 157 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.73324041 |
| 158 | * response to interferon-gamma (GO:0034341) | 2.72926692 |
| 159 | dendritic cell differentiation (GO:0097028) | 2.72888744 |
| 160 | lymphocyte chemotaxis (GO:0048247) | 2.72674309 |
| 161 | positive regulation of interferon-beta production (GO:0032728) | 2.72144165 |
| 162 | neutrophil activation involved in immune response (GO:0002283) | 2.71282895 |
| 163 | regulation of T cell tolerance induction (GO:0002664) | 2.71254716 |
| 164 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.71236116 |
| 165 | apoptotic DNA fragmentation (GO:0006309) | 2.70282034 |
| 166 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.69857183 |
| 167 | coenzyme catabolic process (GO:0009109) | 2.69055909 |
| 168 | histone H3 acetylation (GO:0043966) | 2.68038146 |
| 169 | DNA damage response, detection of DNA damage (GO:0042769) | 2.68023030 |
| 170 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.67662259 |
| 171 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67162238 |
| 172 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.66783440 |
| 173 | regulation of interleukin-12 production (GO:0032655) | 2.66728351 |
| 174 | regulation of T-helper cell differentiation (GO:0045622) | 2.66452235 |
| 175 | cellular response to interferon-beta (GO:0035458) | 2.66069274 |
| 176 | tachykinin receptor signaling pathway (GO:0007217) | 2.66060458 |
| 177 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.65733334 |
| 178 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.65673455 |
| 179 | nucleoside transport (GO:0015858) | 2.64962928 |
| 180 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64666772 |
| 181 | response to host immune response (GO:0052572) | 2.64666772 |
| 182 | interferon-gamma secretion (GO:0072643) | 2.62756091 |
| 183 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.61314439 |
| 184 | cardiovascular system development (GO:0072358) | 2.61075161 |
| 185 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.60793630 |
| 186 | regulation of hippo signaling (GO:0035330) | 2.60125275 |
| 187 | mannose metabolic process (GO:0006013) | 2.59342969 |
| 188 | determination of adult lifespan (GO:0008340) | 2.58922368 |
| 189 | protein localization to chromosome (GO:0034502) | 2.58896928 |
| 190 | mitotic G2/M transition checkpoint (GO:0044818) | 2.58714477 |
| 191 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58177996 |
| 192 | response to host (GO:0075136) | 2.58177996 |
| 193 | response to host defenses (GO:0052200) | 2.58177996 |
| 194 | membrane disassembly (GO:0030397) | 2.58170630 |
| 195 | nuclear envelope disassembly (GO:0051081) | 2.58170630 |
| 196 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.56991906 |
| 197 | regulation of podosome assembly (GO:0071801) | 2.56776366 |
| 198 | tolerance induction (GO:0002507) | 2.56567609 |
| 199 | * defense response to virus (GO:0051607) | 2.55992025 |
| 200 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.55448949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.42694005 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.16707907 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.16707907 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.16707907 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.98778717 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70875687 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.19371214 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.96631857 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.95684876 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.84119544 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.74293133 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.60186710 |
| 13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.58073363 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.56198598 |
| 15 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.54275716 |
| 16 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.51231618 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.36363075 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36284455 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35729743 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33941449 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24368364 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22207255 |
| 23 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.21754784 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18964565 |
| 25 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18233851 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.17895353 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.17099285 |
| 28 | * TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.16514422 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14988159 |
| 30 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12670995 |
| 31 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11181222 |
| 32 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.08977697 |
| 33 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.02029335 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.96308520 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.95405083 |
| 36 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.95262191 |
| 37 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.94566523 |
| 38 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.92593961 |
| 39 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.92255931 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87052533 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86644719 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84132871 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81998699 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76851410 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.75051892 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70839301 |
| 47 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.69626453 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69293747 |
| 49 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.67599155 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63620856 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.62900517 |
| 52 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.60849362 |
| 53 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.57810550 |
| 54 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.56492269 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.55306481 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53067519 |
| 57 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.52955744 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52438293 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51772834 |
| 60 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48983456 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 1.48568630 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48432736 |
| 63 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47995901 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.45217617 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44475001 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43946052 |
| 67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43609502 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43566648 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42864156 |
| 70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41620711 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39791967 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35562982 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34478807 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32782620 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32769608 |
| 76 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.30557821 |
| 77 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.29824363 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29678632 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29671720 |
| 80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28477944 |
| 81 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26729591 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26643342 |
| 83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26434601 |
| 84 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25067966 |
| 85 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25004294 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23519181 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23466944 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23438626 |
| 89 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.23265619 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.23091721 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23073449 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22886439 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22114012 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21313252 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20589507 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20511208 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18823076 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18454958 |
| 99 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.17737065 |
| 100 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.17669134 |
| 101 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17522959 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17470137 |
| 103 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.17084937 |
| 104 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.15504333 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15414236 |
| 106 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.15199042 |
| 107 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.14996268 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14775759 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13490065 |
| 110 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13025304 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11982942 |
| 112 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11832915 |
| 113 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11749534 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11400998 |
| 115 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11114043 |
| 116 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.09628071 |
| 117 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08832818 |
| 118 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08621280 |
| 119 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06284737 |
| 120 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.06152842 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05707118 |
| 122 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05602558 |
| 123 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04918070 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04879512 |
| 125 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04879410 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04708704 |
| 127 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04585229 |
| 128 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04134864 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04124247 |
| 130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03880008 |
| 131 | P68_20966046_ChIP-Seq_HELA_Human | 1.03140482 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02095570 |
| 133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02011341 |
| 134 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01446547 |
| 135 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01176715 |
| 136 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00811526 |
| 137 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00614771 |
| 138 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00109671 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99683661 |
| 140 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99174085 |
| 141 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99039632 |
| 142 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99031876 |
| 143 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98818612 |
| 144 | MYB_26560356_Chip-Seq_TH1_Human | 0.97785303 |
| 145 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97349868 |
| 146 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97193295 |
| 147 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97173434 |
| 148 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96800829 |
| 149 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.96548126 |
| 150 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.95370733 |
| 151 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94907255 |
| 152 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94883698 |
| 153 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94860471 |
| 154 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94530480 |
| 155 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94025591 |
| 156 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92740011 |
| 157 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92518949 |
| 158 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92167792 |
| 159 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91307033 |
| 160 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.87471491 |
| 161 | * MAF_26560356_Chip-Seq_TH1_Human | 0.87159927 |
| 162 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.86879513 |
| 163 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.86027822 |
| 164 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85623745 |
| 165 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.84736771 |
| 166 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84696673 |
| 167 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.83684921 |
| 168 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83566706 |
| 169 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83514155 |
| 170 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83316588 |
| 171 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.83178611 |
| 172 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.83085830 |
| 173 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82477289 |
| 174 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81776176 |
| 175 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81716688 |
| 176 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.81052635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.47449167 |
| 2 | MP0003724_increased_susceptibility_to | 3.90291498 |
| 3 | MP0002254_reproductive_system_inflammat | 3.89122566 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.74840398 |
| 5 | MP0008057_abnormal_DNA_replication | 3.65306718 |
| 6 | MP0003011_delayed_dark_adaptation | 3.25811433 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.15033479 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 3.11701921 |
| 9 | MP0009785_altered_susceptibility_to | 3.02730611 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.88067359 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.83613796 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.80160838 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.76030986 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.71839699 |
| 15 | * MP0005025_abnormal_response_to | 2.56372913 |
| 16 | MP0004510_myositis | 2.52315910 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.43710470 |
| 18 | MP0002419_abnormal_innate_immunity | 2.42795584 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.30746054 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.28904353 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.20628536 |
| 22 | MP0003077_abnormal_cell_cycle | 2.15206162 |
| 23 | MP0005394_taste/olfaction_phenotype | 2.12899965 |
| 24 | MP0005499_abnormal_olfactory_system | 2.12899965 |
| 25 | MP0009278_abnormal_bone_marrow | 2.10364075 |
| 26 | MP0004947_skin_inflammation | 2.08559932 |
| 27 | MP0002332_abnormal_exercise_endurance | 2.02951826 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.96635366 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.96275379 |
| 30 | MP0004858_abnormal_nervous_system | 1.95603452 |
| 31 | MP0010094_abnormal_chromosome_stability | 1.92944047 |
| 32 | MP0001672_abnormal_embryogenesis/_devel | 1.88991441 |
| 33 | MP0005380_embryogenesis_phenotype | 1.88991441 |
| 34 | MP0005451_abnormal_body_composition | 1.86504430 |
| 35 | MP0003121_genomic_imprinting | 1.81056706 |
| 36 | MP0009840_abnormal_foam_cell | 1.78605407 |
| 37 | MP0002088_abnormal_embryonic_growth/wei | 1.77827932 |
| 38 | MP0003984_embryonic_growth_retardation | 1.77079205 |
| 39 | MP0006082_CNS_inflammation | 1.76106438 |
| 40 | MP0009764_decreased_sensitivity_to | 1.75809323 |
| 41 | * MP0000350_abnormal_cell_proliferation | 1.67400421 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.64979248 |
| 43 | MP0000490_abnormal_crypts_of | 1.63737934 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.63586136 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.62180284 |
| 46 | MP0003075_altered_response_to | 1.61509253 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.59306811 |
| 48 | MP0003122_maternal_imprinting | 1.58067166 |
| 49 | MP0002086_abnormal_extraembryonic_tissu | 1.51147130 |
| 50 | MP0000343_altered_response_to | 1.50539144 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.49188460 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.48780872 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.47869822 |
| 54 | MP0008469_abnormal_protein_level | 1.46242831 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.44832030 |
| 56 | MP0003279_aneurysm | 1.44287176 |
| 57 | MP0001293_anophthalmia | 1.43177015 |
| 58 | MP0001849_ear_inflammation | 1.41270540 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.40898800 |
| 60 | MP0008004_abnormal_stomach_pH | 1.39881930 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.39773098 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.38481467 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.38310843 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.38002029 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.37085944 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.36664910 |
| 67 | MP0001800_abnormal_humoral_immune | 1.35740023 |
| 68 | MP0003091_abnormal_cell_migration | 1.32972716 |
| 69 | MP0001853_heart_inflammation | 1.32920771 |
| 70 | MP0002085_abnormal_embryonic_tissue | 1.30782896 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.29596266 |
| 72 | MP0002933_joint_inflammation | 1.28985283 |
| 73 | MP0005390_skeleton_phenotype | 1.25194119 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.24627851 |
| 75 | MP0008007_abnormal_cellular_replicative | 1.24193999 |
| 76 | MP0005387_immune_system_phenotype | 1.24012185 |
| 77 | MP0001790_abnormal_immune_system | 1.24012185 |
| 78 | MP0000313_abnormal_cell_death | 1.22933225 |
| 79 | MP0001730_embryonic_growth_arrest | 1.22736538 |
| 80 | MP0002092_abnormal_eye_morphology | 1.22665176 |
| 81 | MP0002084_abnormal_developmental_patter | 1.21076376 |
| 82 | MP0002722_abnormal_immune_system | 1.21051646 |
| 83 | MP0002398_abnormal_bone_marrow | 1.19789178 |
| 84 | MP0002127_abnormal_cardiovascular_syste | 1.19439780 |
| 85 | MP0003123_paternal_imprinting | 1.18330705 |
| 86 | MP0004197_abnormal_fetal_growth/weight/ | 1.18162586 |
| 87 | MP0005164_abnormal_response_to | 1.16223892 |
| 88 | MP0001873_stomach_inflammation | 1.15395348 |
| 89 | MP0005023_abnormal_wound_healing | 1.14170873 |
| 90 | MP0000685_abnormal_immune_system | 1.13945216 |
| 91 | MP0003938_abnormal_ear_development | 1.13392515 |
| 92 | MP0005166_decreased_susceptibility_to | 1.12609538 |
| 93 | MP0001348_abnormal_lacrimal_gland | 1.10634083 |
| 94 | MP0010030_abnormal_orbit_morphology | 1.07729543 |
| 95 | MP0001697_abnormal_embryo_size | 1.07711895 |
| 96 | MP0004133_heterotaxia | 1.04799255 |
| 97 | MP0000858_altered_metastatic_potential | 1.03879419 |
| 98 | MP0002080_prenatal_lethality | 1.03358855 |
| 99 | MP0003448_altered_tumor_morphology | 1.02046347 |
| 100 | MP0003436_decreased_susceptibility_to | 1.01686425 |
| 101 | MP0005266_abnormal_metabolism | 1.01237556 |
| 102 | MP0001542_abnormal_bone_strength | 1.00137715 |
| 103 | MP0005671_abnormal_response_to | 0.99996904 |
| 104 | MP0008932_abnormal_embryonic_tissue | 0.99930990 |
| 105 | MP0002932_abnormal_joint_morphology | 0.99841286 |
| 106 | * MP0002429_abnormal_blood_cell | 0.99641489 |
| 107 | * MP0002019_abnormal_tumor_incidence | 0.99122573 |
| 108 | MP0000604_amyloidosis | 0.99043237 |
| 109 | MP0002405_respiratory_system_inflammati | 0.98378491 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.98375896 |
| 111 | MP0002132_abnormal_respiratory_system | 0.97684727 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.97270286 |
| 113 | * MP0000716_abnormal_immune_system | 0.96455385 |
| 114 | MP0008058_abnormal_DNA_repair | 0.96197193 |
| 115 | MP0001958_emphysema | 0.95840012 |
| 116 | MP0003763_abnormal_thymus_physiology | 0.95779691 |
| 117 | MP0006054_spinal_hemorrhage | 0.95569414 |
| 118 | MP0008770_decreased_survivor_rate | 0.94904609 |
| 119 | MP0003828_pulmonary_edema | 0.94420670 |
| 120 | MP0003045_fibrosis | 0.93640265 |
| 121 | MP0008260_abnormal_autophagy | 0.93581838 |
| 122 | MP0005000_abnormal_immune_tolerance | 0.92980491 |
| 123 | MP0004883_abnormal_blood_vessel | 0.92232143 |
| 124 | MP0002452_abnormal_antigen_presenting | 0.92034913 |
| 125 | MP0002970_abnormal_white_adipose | 0.91707899 |
| 126 | MP0009763_increased_sensitivity_to | 0.91067052 |
| 127 | MP0000249_abnormal_blood_vessel | 0.90823242 |
| 128 | MP0002925_abnormal_cardiovascular_devel | 0.90459763 |
| 129 | MP0001663_abnormal_digestive_system | 0.89585224 |
| 130 | MP0003806_abnormal_nucleotide_metabolis | 0.88977648 |
| 131 | MP0003787_abnormal_imprinting | 0.88005001 |
| 132 | MP0002420_abnormal_adaptive_immunity | 0.87954993 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.86883047 |
| 134 | MP0001819_abnormal_immune_cell | 0.86750099 |
| 135 | MP0000465_gastrointestinal_hemorrhage | 0.85474058 |
| 136 | MP0003119_abnormal_digestive_system | 0.84662888 |
| 137 | MP0000432_abnormal_head_morphology | 0.84064416 |
| 138 | MP0009333_abnormal_splenocyte_physiolog | 0.83955190 |
| 139 | MP0002723_abnormal_immune_serum | 0.83453601 |
| 140 | MP0003566_abnormal_cell_adhesion | 0.81927723 |
| 141 | MP0005165_increased_susceptibility_to | 0.80647456 |
| 142 | MP0003866_abnormal_defecation | 0.80391685 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.80075654 |
| 144 | MP0000428_abnormal_craniofacial_morphol | 0.79897305 |
| 145 | MP0001851_eye_inflammation | 0.79537367 |
| 146 | MP0010155_abnormal_intestine_physiology | 0.76764417 |
| 147 | MP0005310_abnormal_salivary_gland | 0.76184277 |
| 148 | MP0003786_premature_aging | 0.75814505 |
| 149 | MP0002114_abnormal_axial_skeleton | 0.75558260 |
| 150 | MP0000049_abnormal_middle_ear | 0.75236680 |
| 151 | MP0002877_abnormal_melanocyte_morpholog | 0.75185928 |
| 152 | MP0001545_abnormal_hematopoietic_system | 0.74639569 |
| 153 | MP0005397_hematopoietic_system_phenotyp | 0.74639569 |
| 154 | MP0003795_abnormal_bone_structure | 0.74185629 |
| 155 | MP0000767_abnormal_smooth_muscle | 0.72732727 |
| 156 | MP0003656_abnormal_erythrocyte_physiolo | 0.72517366 |
| 157 | MP0003690_abnormal_glial_cell | 0.72502888 |
| 158 | MP0005275_abnormal_skin_tensile | 0.69788283 |
| 159 | MP0008874_decreased_physiological_sensi | 0.69271620 |
| 160 | MP0005595_abnormal_vascular_smooth | 0.68909754 |
| 161 | MP0009765_abnormal_xenobiotic_induced | 0.65311766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.18996261 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.75931446 |
| 3 | Multiple enchondromatosis (HP:0005701) | 4.72994411 |
| 4 | Ependymoma (HP:0002888) | 4.59064952 |
| 5 | Myositis (HP:0100614) | 4.56091275 |
| 6 | Orchitis (HP:0100796) | 4.53310026 |
| 7 | Hepatoblastoma (HP:0002884) | 4.47540057 |
| 8 | Rib fusion (HP:0000902) | 4.39938491 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.16605408 |
| 10 | Optic neuritis (HP:0100653) | 4.16605408 |
| 11 | Eczematoid dermatitis (HP:0000976) | 4.09467398 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.96347722 |
| 13 | Abnormality of the lower motor neuron (HP:0002366) | 3.85375941 |
| 14 | Neoplasm of striated muscle (HP:0009728) | 3.77430013 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.76645338 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.75297651 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.75297651 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.75297651 |
| 19 | Rhabdomyosarcoma (HP:0002859) | 3.71836278 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.58641501 |
| 21 | Chromsome breakage (HP:0040012) | 3.55209332 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.42760779 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.42211772 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.41647474 |
| 25 | Increased IgE level (HP:0003212) | 3.38126808 |
| 26 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.37756087 |
| 27 | Stomatitis (HP:0010280) | 3.20112059 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.17770012 |
| 29 | Astrocytoma (HP:0009592) | 3.12597651 |
| 30 | Abnormality of the astrocytes (HP:0100707) | 3.12597651 |
| 31 | Embryonal renal neoplasm (HP:0011794) | 3.11779955 |
| 32 | Keratoconjunctivitis sicca (HP:0001097) | 3.07655903 |
| 33 | Recurrent fungal infections (HP:0002841) | 3.07380676 |
| 34 | Hypochromic anemia (HP:0001931) | 3.07227078 |
| 35 | Vasculitis (HP:0002633) | 3.05994482 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 3.02237886 |
| 37 | Fused cervical vertebrae (HP:0002949) | 3.01119467 |
| 38 | Loss of speech (HP:0002371) | 3.00325899 |
| 39 | Recurrent viral infections (HP:0004429) | 2.92340658 |
| 40 | Trismus (HP:0000211) | 2.91536931 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.91493029 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.87770508 |
| 43 | Testicular atrophy (HP:0000029) | 2.85686034 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.84958853 |
| 45 | Rectal fistula (HP:0100590) | 2.83871246 |
| 46 | Rectovaginal fistula (HP:0000143) | 2.83871246 |
| 47 | Abnormality of the salivary glands (HP:0010286) | 2.81351205 |
| 48 | Intestinal fistula (HP:0100819) | 2.80789704 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77365714 |
| 50 | Emphysema (HP:0002097) | 2.73348301 |
| 51 | Partial duplication of thumb phalanx (HP:0009944) | 2.72724896 |
| 52 | Gastrointestinal stroma tumor (HP:0100723) | 2.72561120 |
| 53 | Increased IgM level (HP:0003496) | 2.71799935 |
| 54 | Hemoptysis (HP:0002105) | 2.70511875 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.69829685 |
| 56 | Nasal polyposis (HP:0100582) | 2.69381031 |
| 57 | Meningitis (HP:0001287) | 2.68871880 |
| 58 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.67861085 |
| 59 | Hypoplasia of the fovea (HP:0007750) | 2.67464725 |
| 60 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.67464725 |
| 61 | Meckel diverticulum (HP:0002245) | 2.64747615 |
| 62 | Short humerus (HP:0005792) | 2.63652295 |
| 63 | Cellulitis (HP:0100658) | 2.60473562 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.59921368 |
| 65 | Preauricular skin tag (HP:0000384) | 2.59510923 |
| 66 | Colitis (HP:0002583) | 2.57678381 |
| 67 | Recurrent skin infections (HP:0001581) | 2.56470260 |
| 68 | Abnormal lung lobation (HP:0002101) | 2.56447265 |
| 69 | Ragged-red muscle fibers (HP:0003200) | 2.56327494 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56005617 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56005617 |
| 72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56005617 |
| 73 | Large earlobe (HP:0009748) | 2.55813689 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.54985464 |
| 75 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.53473826 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53256709 |
| 77 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53256709 |
| 78 | Abnormality of the ileum (HP:0001549) | 2.49995351 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49417991 |
| 80 | Vaginal fistula (HP:0004320) | 2.46257410 |
| 81 | Gingivitis (HP:0000230) | 2.44520160 |
| 82 | Skin tags (HP:0010609) | 2.43535595 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42836322 |
| 84 | Obstructive lung disease (HP:0006536) | 2.42836322 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42779905 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.42779905 |
| 87 | Amyotrophic lateral sclerosis (HP:0007354) | 2.42629018 |
| 88 | Combined immunodeficiency (HP:0005387) | 2.41764789 |
| 89 | Spontaneous hematomas (HP:0007420) | 2.41085301 |
| 90 | Abnormality of the nasal mucosa (HP:0000433) | 2.40266294 |
| 91 | Impulsivity (HP:0100710) | 2.38487429 |
| 92 | Supernumerary spleens (HP:0009799) | 2.37026382 |
| 93 | Reduced antithrombin III activity (HP:0001976) | 2.36363774 |
| 94 | Partial duplication of the phalanx of hand (HP:0009999) | 2.35806796 |
| 95 | Medulloblastoma (HP:0002885) | 2.35170759 |
| 96 | Abnormal cartilage morphology (HP:0002763) | 2.34292041 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34079833 |
| 98 | Encephalitis (HP:0002383) | 2.32661172 |
| 99 | Glioma (HP:0009733) | 2.31378120 |
| 100 | Cheilitis (HP:0100825) | 2.31155186 |
| 101 | Gastrointestinal inflammation (HP:0004386) | 2.30398554 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.28838183 |
| 103 | Spondylolisthesis (HP:0003302) | 2.28057476 |
| 104 | Inflammation of the large intestine (HP:0002037) | 2.26468725 |
| 105 | Abnormality of the pericardium (HP:0001697) | 2.25481710 |
| 106 | Increased serum ferritin (HP:0003281) | 2.25186224 |
| 107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24115653 |
| 108 | Horizontal nystagmus (HP:0000666) | 2.23050642 |
| 109 | Pustule (HP:0200039) | 2.22039458 |
| 110 | Peritonitis (HP:0002586) | 2.22006380 |
| 111 | Hematochezia (HP:0002573) | 2.19187054 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19127763 |
| 113 | Arterial thrombosis (HP:0004420) | 2.18048185 |
| 114 | Shawl scrotum (HP:0000049) | 2.17684709 |
| 115 | Urticaria (HP:0001025) | 2.17604573 |
| 116 | Petechiae (HP:0000967) | 2.16671495 |
| 117 | Thin bony cortex (HP:0002753) | 2.16483692 |
| 118 | Anomalous pulmonary venous return (HP:0010772) | 2.16028265 |
| 119 | Malnutrition (HP:0004395) | 2.15384956 |
| 120 | Polygenic inheritance (HP:0010982) | 2.13905357 |
| 121 | Myelodysplasia (HP:0002863) | 2.13134675 |
| 122 | Amyloidosis (HP:0011034) | 2.11838858 |
| 123 | Prolonged bleeding time (HP:0003010) | 2.10903845 |
| 124 | Small intestinal stenosis (HP:0012848) | 2.09642770 |
| 125 | Duodenal stenosis (HP:0100867) | 2.09642770 |
| 126 | Abnormality of the pleura (HP:0002103) | 2.09383319 |
| 127 | Gangrene (HP:0100758) | 2.09002655 |
| 128 | Protrusio acetabuli (HP:0003179) | 2.08472211 |
| 129 | Abnormality of chromosome segregation (HP:0002916) | 2.07797987 |
| 130 | Short 5th finger (HP:0009237) | 2.07638904 |
| 131 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.07108637 |
| 132 | Villous atrophy (HP:0011473) | 2.07108637 |
| 133 | Restrictive lung disease (HP:0002091) | 2.06502555 |
| 134 | Pseudobulbar signs (HP:0002200) | 2.06171916 |
| 135 | Autoimmune hemolytic anemia (HP:0001890) | 2.03986232 |
| 136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03666728 |
| 137 | Recurrent bronchitis (HP:0002837) | 2.02778557 |
| 138 | Progressive muscle weakness (HP:0003323) | 2.02145609 |
| 139 | Neoplasm of the oral cavity (HP:0100649) | 2.01358198 |
| 140 | Purpura (HP:0000979) | 2.01305557 |
| 141 | Vertebral fusion (HP:0002948) | 2.00313229 |
| 142 | Hypertensive crisis (HP:0100735) | 1.99815604 |
| 143 | Bifid tongue (HP:0010297) | 1.99662889 |
| 144 | Nuclear cataract (HP:0100018) | 1.99647182 |
| 145 | Vertebral compression fractures (HP:0002953) | 1.96413269 |
| 146 | Tongue fasciculations (HP:0001308) | 1.94471439 |
| 147 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94212755 |
| 148 | Agammaglobulinemia (HP:0004432) | 1.93919308 |
| 149 | Cervical subluxation (HP:0003308) | 1.93747768 |
| 150 | Chest pain (HP:0100749) | 1.93256088 |
| 151 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.93173079 |
| 152 | Axonal loss (HP:0003447) | 1.92289418 |
| 153 | Epistaxis (HP:0000421) | 1.91749802 |
| 154 | Supernumerary ribs (HP:0005815) | 1.91432074 |
| 155 | Upper motor neuron abnormality (HP:0002127) | 1.90581371 |
| 156 | Generalized hypotonia (HP:0001290) | 1.89901267 |
| 157 | Abnormality of the preputium (HP:0100587) | 1.89240321 |
| 158 | Joint stiffness (HP:0001387) | 1.89044966 |
| 159 | Renal duplication (HP:0000075) | 1.88626732 |
| 160 | Arthralgia (HP:0002829) | 1.88515614 |
| 161 | Increased connective tissue (HP:0009025) | 1.87358792 |
| 162 | Microretrognathia (HP:0000308) | 1.87342847 |
| 163 | Hypopigmentation of the fundus (HP:0007894) | 1.87124392 |
| 164 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.87029402 |
| 165 | Missing ribs (HP:0000921) | 1.86884644 |
| 166 | Abnormality of the fovea (HP:0000493) | 1.86512978 |
| 167 | Lymphopenia (HP:0001888) | 1.85763044 |
| 168 | Periauricular skin pits (HP:0100277) | 1.85673615 |
| 169 | Preauricular pit (HP:0004467) | 1.85673615 |
| 170 | Chronic otitis media (HP:0000389) | 1.84263613 |
| 171 | Glossoptosis (HP:0000162) | 1.84226096 |
| 172 | Acne (HP:0001061) | 1.84140969 |
| 173 | Abnormality of the musculature of the hand (HP:0001421) | 1.83740075 |
| 174 | Anorexia (HP:0002039) | 1.83203293 |
| 175 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.82962725 |
| 176 | Leukocytosis (HP:0001974) | 1.82522213 |
| 177 | Abnormality of iron homeostasis (HP:0011031) | 1.82315718 |
| 178 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81821616 |
| 179 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.81388723 |
| 180 | Glomerulopathy (HP:0100820) | 1.81319027 |
| 181 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.81294682 |
| 182 | Pendular nystagmus (HP:0012043) | 1.81262650 |
| 183 | Hand muscle atrophy (HP:0009130) | 1.81222487 |
| 184 | Atresia of the external auditory canal (HP:0000413) | 1.81099606 |
| 185 | Polycythemia (HP:0001901) | 1.80688896 |
| 186 | Keratitis (HP:0000491) | 1.80352740 |
| 187 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.79976335 |
| 188 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.79641858 |
| 189 | Neoplasm of the heart (HP:0100544) | 1.79581452 |
| 190 | Abnormality of the pulmonary veins (HP:0011718) | 1.77974349 |
| 191 | Selective tooth agenesis (HP:0001592) | 1.76364847 |
| 192 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.75833954 |
| 193 | Angiofibromas (HP:0010615) | 1.74452702 |
| 194 | Adenoma sebaceum (HP:0009720) | 1.74452702 |
| 195 | Abnormality of the duodenum (HP:0002246) | 1.74326793 |
| 196 | Volvulus (HP:0002580) | 1.74170339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.45992545 |
| 2 | ERN1 | 4.80696776 |
| 3 | GRK6 | 4.07641431 |
| 4 | GRK5 | 3.72037756 |
| 5 | IRAK3 | 3.00313613 |
| 6 | CSF1R | 2.95878257 |
| 7 | TAOK2 | 2.89330032 |
| 8 | STK10 | 2.87356469 |
| 9 | TGFBR2 | 2.78970634 |
| 10 | TBK1 | 2.59793539 |
| 11 | PRPF4B | 2.56600687 |
| 12 | RIPK4 | 2.56259269 |
| 13 | TTK | 2.45219500 |
| 14 | MAP3K14 | 2.44477756 |
| 15 | GRK1 | 2.35178714 |
| 16 | ADRBK2 | 2.33913648 |
| 17 | MATK | 2.14227870 |
| 18 | IKBKE | 2.07732836 |
| 19 | IRAK4 | 2.05563936 |
| 20 | MAP3K10 | 1.97209617 |
| 21 | TYRO3 | 1.93120752 |
| 22 | CDK7 | 1.83015692 |
| 23 | EPHA2 | 1.77148333 |
| 24 | EPHB1 | 1.74394077 |
| 25 | GRK7 | 1.72427260 |
| 26 | MAP3K11 | 1.71569576 |
| 27 | CDC42BPA | 1.66398700 |
| 28 | MAP3K3 | 1.65120382 |
| 29 | JAK1 | 1.63858663 |
| 30 | SMG1 | 1.63095885 |
| 31 | MOS | 1.60257982 |
| 32 | DDR2 | 1.56323788 |
| 33 | MAP4K1 | 1.51169525 |
| 34 | WNK1 | 1.49802385 |
| 35 | MAP3K13 | 1.44502039 |
| 36 | TAOK1 | 1.39556278 |
| 37 | FGFR3 | 1.36181566 |
| 38 | PAK4 | 1.30526709 |
| 39 | CDC7 | 1.26401172 |
| 40 | PRKG2 | 1.20710675 |
| 41 | NEK2 | 1.20225120 |
| 42 | TNK2 | 1.15368568 |
| 43 | PLK1 | 1.13699472 |
| 44 | CSK | 1.10981188 |
| 45 | CAMK4 | 1.10022463 |
| 46 | TXK | 1.04042350 |
| 47 | ALK | 1.00370394 |
| 48 | SIK3 | 0.98730884 |
| 49 | MARK2 | 0.98525204 |
| 50 | RPS6KB2 | 0.98408325 |
| 51 | CDK4 | 0.95179550 |
| 52 | EPHA3 | 0.94485966 |
| 53 | MAP3K1 | 0.94378551 |
| 54 | IRAK1 | 0.93289651 |
| 55 | CHEK1 | 0.92583253 |
| 56 | BLK | 0.90241612 |
| 57 | BUB1 | 0.85223134 |
| 58 | WEE1 | 0.83385938 |
| 59 | FGR | 0.82836073 |
| 60 | IKBKB | 0.82634799 |
| 61 | EEF2K | 0.79380066 |
| 62 | TAOK3 | 0.79041013 |
| 63 | LYN | 0.78840356 |
| 64 | JAK2 | 0.78380369 |
| 65 | FES | 0.75176379 |
| 66 | MAP3K6 | 0.74832152 |
| 67 | TESK1 | 0.73809769 |
| 68 | BRD4 | 0.72734437 |
| 69 | MTOR | 0.72041316 |
| 70 | MARK3 | 0.70844601 |
| 71 | PDGFRA | 0.68900572 |
| 72 | MAP3K7 | 0.68733049 |
| 73 | TYK2 | 0.68718369 |
| 74 | TTN | 0.68025905 |
| 75 | ADRBK1 | 0.66853803 |
| 76 | JAK3 | 0.66726384 |
| 77 | AKT2 | 0.66686859 |
| 78 | MAPK11 | 0.66566755 |
| 79 | PIM1 | 0.64920851 |
| 80 | NTRK1 | 0.64538541 |
| 81 | TRPM7 | 0.63588463 |
| 82 | KIT | 0.63433872 |
| 83 | TLK1 | 0.62713224 |
| 84 | * HIPK2 | 0.61358296 |
| 85 | RPS6KA2 | 0.60969996 |
| 86 | STK4 | 0.60106729 |
| 87 | IRAK2 | 0.60001948 |
| 88 | RPS6KC1 | 0.59808256 |
| 89 | RPS6KL1 | 0.59808256 |
| 90 | CDK2 | 0.59498451 |
| 91 | MAP3K5 | 0.59096279 |
| 92 | FLT3 | 0.58706944 |
| 93 | PTK6 | 0.58576630 |
| 94 | EIF2AK2 | 0.57485546 |
| 95 | ITK | 0.57286032 |
| 96 | BMPR2 | 0.56853245 |
| 97 | AURKB | 0.55367771 |
| 98 | AKT3 | 0.53814667 |
| 99 | CHUK | 0.53635826 |
| 100 | TESK2 | 0.53003233 |
| 101 | PDPK1 | 0.52441614 |
| 102 | ATM | 0.51443489 |
| 103 | MAP2K6 | 0.51017529 |
| 104 | RPS6KA6 | 0.50941465 |
| 105 | * MAPK7 | 0.50418888 |
| 106 | BMX | 0.49008566 |
| 107 | ATR | 0.48990634 |
| 108 | KDR | 0.47274325 |
| 109 | MAP3K8 | 0.47197935 |
| 110 | DYRK3 | 0.45945498 |
| 111 | LMTK2 | 0.45918693 |
| 112 | LRRK2 | 0.45907590 |
| 113 | CLK1 | 0.44527952 |
| 114 | PRKCI | 0.44265900 |
| 115 | PDK1 | 0.42272320 |
| 116 | HCK | 0.42010911 |
| 117 | ZAP70 | 0.41935135 |
| 118 | MAPK12 | 0.41076562 |
| 119 | ABL2 | 0.41048364 |
| 120 | PKN2 | 0.39962009 |
| 121 | SIK2 | 0.38867347 |
| 122 | RIPK1 | 0.38421509 |
| 123 | MAP2K2 | 0.37035670 |
| 124 | DAPK3 | 0.36746584 |
| 125 | AURKA | 0.35481777 |
| 126 | LCK | 0.34244949 |
| 127 | PRKD2 | 0.33420174 |
| 128 | * CHEK2 | 0.33082642 |
| 129 | NME2 | 0.32390984 |
| 130 | TRIB3 | 0.31827497 |
| 131 | PAK1 | 0.31392358 |
| 132 | BTK | 0.31091491 |
| 133 | MAPKAPK3 | 0.30530547 |
| 134 | SYK | 0.29662410 |
| 135 | SIK1 | 0.28888377 |
| 136 | CDK1 | 0.28277875 |
| 137 | MAP2K4 | 0.27641480 |
| 138 | IGF1R | 0.27584271 |
| 139 | PRKCD | 0.27295978 |
| 140 | INSR | 0.26817311 |
| 141 | MAPK14 | 0.25891222 |
| 142 | * MAPK1 | 0.24711082 |
| 143 | ICK | 0.24481080 |
| 144 | MAP2K3 | 0.23348847 |
| 145 | PIM2 | 0.23216906 |
| 146 | TGFBR1 | 0.23182932 |
| 147 | MELK | 0.22854333 |
| 148 | FGFR4 | 0.22146419 |
| 149 | MAPK4 | 0.22119093 |
| 150 | MAPKAPK2 | 0.21994803 |
| 151 | CDK6 | 0.21931048 |
| 152 | PTK2 | 0.21882292 |
| 153 | SRPK1 | 0.20287677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.98828944 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.80784279 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.72863119 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.83964469 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.75553101 |
| 6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.53788820 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46745908 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.42971738 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.40605089 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.38967181 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.30760396 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23113832 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.10481446 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.06787660 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 2.06218877 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 1.89392983 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.88195890 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.84999739 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.83725979 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.82395842 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74898522 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.74452291 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74313121 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.71667307 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.70692098 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.69816938 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68324198 |
| 28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65846081 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60672654 |
| 30 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.59579955 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.56249439 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.56087332 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.52899610 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52841476 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41253757 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.35918116 |
| 37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.35470878 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34950934 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.33890859 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.32030274 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26782885 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.25702197 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24334616 |
| 44 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.22604635 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20037619 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14815437 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14388564 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.14284530 |
| 49 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.12076921 |
| 50 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09854210 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09636406 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08873153 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08460570 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07847386 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03788395 |
| 56 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.03397672 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02706007 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02367545 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01538457 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.01461071 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.97639566 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96472794 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.96354839 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96132363 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.95937116 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93268279 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93073704 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92220511 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.91477553 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.89975768 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86847203 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83148256 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82926670 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81717535 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80169715 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79416005 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78064242 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75614124 |
| 79 | RNA polymerase_Homo sapiens_hsa03020 | 0.73905324 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73883888 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73430190 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72612972 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72389688 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71999174 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71622906 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71054482 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70953667 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.69372610 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67718204 |
| 90 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.65463360 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61595413 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60794003 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60665924 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.60592223 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58766495 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58374662 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57814104 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57431806 |
| 99 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56283957 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55924404 |
| 101 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55727232 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.54482773 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54134227 |
| 104 | * Influenza A_Homo sapiens_hsa05164 | 0.53487405 |
| 105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53479269 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52877005 |
| 107 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52482996 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.52443727 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.52193131 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.52003041 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50149775 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49665666 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49439068 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48963421 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48372225 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48130053 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47531234 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.47068737 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45827002 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44981330 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.44941581 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43394535 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42211951 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40280843 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39854471 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39393363 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39351363 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.38733419 |
| 129 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38508150 |
| 130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38470353 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38408550 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37993370 |
| 133 | * Endocytosis_Homo sapiens_hsa04144 | 0.37717296 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.37319243 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37229704 |
| 136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36922588 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36347434 |
| 138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35675598 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35493366 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35370182 |
| 141 | Adherens junction_Homo sapiens_hsa04520 | 0.34723768 |
| 142 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33356374 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32588019 |
| 144 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31635364 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29155279 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26870255 |
| 147 | Prostate cancer_Homo sapiens_hsa05215 | 0.26489865 |
| 148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23315938 |

